<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04715503</url>
  </required_header>
  <id_info>
    <org_study_id>T225/2020</org_study_id>
    <nct_id>NCT04715503</nct_id>
  </id_info>
  <brief_title>PET-imaging of Unruptured Intracranial Aneurysm Inflammation</brief_title>
  <acronym>PET-IA</acronym>
  <official_title>PET-imaging of Unruptured Intracranial Aneurysm Inflammation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Turku</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to determine if PET-imaging can be used to evaluate&#xD;
      inflammation level of intracranial aneurysms, thus helping to evaluate the rupture risk of&#xD;
      intracranial aneurysm.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study subjects are patients who are diagnosed with an unruptured saccular intracranial&#xD;
      aneurysm and planned for elective surgical treatment of intracranial aneurysms. Prior the&#xD;
      planned surgery, all study subjects will undergo PET-imaging of the brain with 18F-FDG- and&#xD;
      68Ga-DOTANOC-tracers targeting glucose metabolism and somatostatin receptors in inflammatory&#xD;
      cells. After PET-imaging, samples for histopathological examination from the intracranial&#xD;
      aneurysm sac will be collected during the surgery from every study subject. Blood samples are&#xD;
      collected prior to aneurysm operation from the routine pre-operative laboratory tests.&#xD;
      Cerebrospinal fluid samples are collected during the surgical procedure from the surgical&#xD;
      site. From blood samples we will evaluate expression of 20 different circulating microRNAs&#xD;
      (miRNA) and the level of tumor necrosis factor-1, interleukin 1 beta, vascular endothelial&#xD;
      growth factor, and evaluate correlations between miRNA expression and SUVmax in PET-imaging&#xD;
      and miRNA and aneurysm histological findings.&#xD;
&#xD;
      Correlation between inflammatory findings in histological studies and PET-imaging will be&#xD;
      evaluated (correlation of SUVmax to aneurysm histological findings).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 14, 2021</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PET-imaging of unruptured intracranial aneurysms</measure>
    <time_frame>1 month</time_frame>
    <description>Uptake of 18F-FDG or 68Ga-DOTANOC in intracranial arterial aneurysms as compared to contra-lateral normal vessel as SUVmax or TBR.&#xD;
Correlation of uptake of 18F-FDG or 68Ga-DOTANOC (SUVmax or TBR) to aneurysm histological findings (CD45, CD3, CD5, CD20, CD138 and CD68, SSTR2, SSTR3 and SSTR5)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Risk factors for intracranial aneurysm inflammation</measure>
    <time_frame>1 month</time_frame>
    <description>Uptake of 18F-FDG or 68Ga-DOTANOC and histological findings correlation to aneurysm size and shape, smoking, hypertension, location of aneurysm.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Intracranial Aneurysm</condition>
  <condition>Cerebral Aneurysm</condition>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>PET-IA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>68Ga-DOTANOC 18F-FDG</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>PET imaging, 18F-FDG</intervention_name>
    <description>PET-MRI with 18F-FDG</description>
    <arm_group_label>PET-IA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>PET imaging, 68Ga-DOTANOC</intervention_name>
    <description>PET-CT with 68Ga-DOTANOC</description>
    <arm_group_label>PET-IA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Fusiform intracranial aneurysms&#xD;
&#xD;
          -  Following medications: Asetylsalisylic acid or non-steroidal anti-inflammatory drugs.&#xD;
&#xD;
          -  Patients who have contraindication for magnetic resonance imaging (Pace Makers,&#xD;
             foreign ferromagnetic bodies or implants)&#xD;
&#xD;
          -  Patients who are allergic to contrast agents.&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Underage persons&#xD;
&#xD;
          -  Patients on somatostatin analogue medication or with known neuroendocrine tumor&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who are diagnosed with unruptured intracranial aneurysm with MRI/MRA or DSA&#xD;
&#xD;
          -  Patients who are planned to undergo surgical treatment (ligation) of the intracranial&#xD;
             aneurysm&#xD;
&#xD;
          -  Age ≥18 and &lt;75 years.&#xD;
&#xD;
          -  Saccular intracranial aneurysm with maximum diameter ≥ 3 mm.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jaakko Rinne, MD, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Turku University Hospital, Neurocenter, Department of Neurosurgery, Division of Clinical Neurosciences, University Of Turku</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antti Saraste, MD, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Turku University Hospital, Heart Centre, University of Turku</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dan Laukka, MD</last_name>
    <phone>+358 2 313 2799</phone>
    <email>dan.laukka@tyks.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <zip>20521</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dan Laukka, MD</last_name>
      <phone>+358 2 313 2799</phone>
      <email>dan.laukka@tyks.fi</email>
    </contact>
    <investigator>
      <last_name>Jaakko Rinne, MD, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dan Laukka, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antti Saraste, MD, Prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Melissa Rahi, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juri Kivelev, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Johanna Kuhmonen, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Riitta Parkkola, MD, Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Gardberg, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 14, 2021</study_first_submitted>
  <study_first_submitted_qc>January 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 20, 2021</study_first_posted>
  <last_update_submitted>January 14, 2021</last_update_submitted>
  <last_update_submitted_qc>January 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Turku University Hospital</investigator_affiliation>
    <investigator_full_name>Jaakko Rinne</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>intracranial aneurysm</keyword>
  <keyword>PET</keyword>
  <keyword>inflammation</keyword>
  <keyword>positron emission tomography</keyword>
  <keyword>rupture risk</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluorodeoxyglucose F18</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

